Rewire Neuro is a leader in development and application of computer vision for biomedical image analysis.
Read more about our major milestones below.
Rewire Neuro is now Rewire AI
Rewire announces partnership with Neurescence Inc.
Rewire Neuro and Neurescence are partnering to bring cutting edge neuronal segmentation and
analysis capability to the field of fluorescence calcium imaging of the nervous system.
Rewire announces partnership with Eppendorf Group’s eLabNext
Biotech Start-up Announces Platform Integration with eLabNext to Accelerate Image Analysis Capabilities, Improve Detection, and Eliminate Human Error through Automated Machine Learning.
Rewire awarded Phase II SBIR grant from NIH
$1.8 million Phase II SBIR will enable the company to expand the commercialization and scaling of its cloud-based, AI-enabled image analysis capabilities to additional markets.
Rewire finalist at BIO International Startup Stadium
Biotech Start-up Attends Nationally Recognized Biology Conference and is Awarded as a Finalist in Pitch Competition
Rewire wins investment at TechFestNW ’21
Biotech Start-up Awarded $145,000 Investment in Pitch Competition
Rewire secures Cougar Cage win from WSU
Biotech Start-Up Awarded Nearly $50,000 in Pitch Competition and Establishes Development Partnership with Public Research University
Rewire winner of Founder’s Live pitch competition
Biotech Start-Up Awarded $27,000 Investment in Pitch Competition
Pipsqueak Pro Launched
Biotech Start-Up Releases Full Version of AI Image Analysis Software
NIH SBIR Phase I Grant Awarded
$225,000 Phase I SBIR will help build the company’s core machine learning (ML) analysis engine, Sightologist.ai™
